Acceleration of in vitro dissolution studies of sustained release dosage form of theophylline and in vitro-in vivo evaluations in terms of correlations

被引:1
|
作者
Ertan, Gokhan [1 ]
Karasulu, Ercument [2 ,3 ]
Ozguney, Isik [1 ]
Karasulu, Yesim [1 ]
Apaydin, Sebnem [3 ]
Kantarci, Gulten [4 ]
Yurdasiper, Aysu [1 ]
Ege, Mehmet Ali [1 ]
机构
[1] Ege Univ, Fac Pharm, Dept Pharmaceut Technol, TR-35100 Izmir, Turkey
[2] Ege Univ, Fac Pharm, Dept Biopharmacy & Pharmacokinet, TR-35100 Izmir, Turkey
[3] Ege Univ, Ctr Drug R&D & Pharmacokinet Applicat, TR-35100 Izmir, Turkey
[4] Ege Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-35100 Izmir, Turkey
关键词
Theophylline; Sustained release; Accelerated release; Correlation; Similarity; PERCUTANEOUS-ABSORPTION; DRUG-RELEASE; FORMULATION; MICROSPHERES; PROFILES;
D O I
10.1007/s13318-011-0049-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the study was to accelerate the dissolution of the sustained release dosage forms using both elevated temperature and high rpm rates. Teokap (R) SR 200 mg pellets were tested by in vitro sustained and accelerated dissolution studies using USP XXIII rotating paddle method. Sustained dissolution studies were carried out for 12 h in phosphate buffer at 37 +/- 0.5 degrees C and 50 rpm. Accelerated dissolution studies were performed for 48 min in distilled water at 90 +/- 1 degrees C and 250 rpm. The results obtained from accelerated and sustained dissolution studies were correlated using both linear and linear kinetic correlation methods by a computer program. While r(2) and maximum error between calculated and observed drug release rates were found to be 0.9129 and 15.9%, respectively, in linear correlation method, these values were observed as 0.9938 and 3.6%, respectively, in linear kinetic correlation method. In vivo plasma concentration data were obtained from six New Zealand rabbits after administration of a single dose of Teokap (R) SR 200 mg pellet. Then, the results of in vivo study were evaluated with in vitro accelerated and sustained dissolution results by applying them to in vitro-in vivo linear correlations. As a result of these correlations, it was shown that the in vitro correlation plots were very similar to the plot which was obtained by the in vivo study (f(2) = 73.81-77.11). This study suggested a way to prevent the loss of time for routine dissolution studies of sustained release preparations for quality control procedures using in vitro accelerated dissolution tests. The storage and quarantine periods of the product in process and process controls in the manufactories could be shortened by this method. Calculation of the in vivo performance of sustained release dosage forms using the results of the accelerated dissolution studies may be counted as another advantage of the method.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 50 条
  • [41] Analysis of level A in vitro-in vivo correlations for an extended-release formulation with limited bioavailability
    Kakhi, Maziar
    Marroum, Patrick
    Chittenden, Jason
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (05) : 262 - 277
  • [42] In vitro and in vivo Studies of a New Sustained Release Formulation of Morphine
    Araico, Amparo
    Torres-Molina, Francisca
    Saadeddin, Anas
    Carcel-Trullols, Jaime
    Alvarez-Fuentes, Josefa
    Holgado, Angeles
    Fernandez-Arevalo, Mercedes
    Peris, Jose-Esteban
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2008, 58 (12): : 647 - 652
  • [43] Comparative in vitro Dissolution and in vivo Bioequivalence of 2 Pentoxifylline Sustained Release Formulations
    Zakeri-Milani, P.
    Ghanbarzadeh, S.
    Valizadeh, H.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (07): : 335 - 339
  • [44] In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior
    Kataoka, Makoto
    Minami, Keiko
    Takagi, Toshihide
    Amidon, Gregory E.
    Yamashita, Shinji
    MOLECULAR PHARMACEUTICS, 2021, 18 (11) : 4122 - 4130
  • [45] Dissolution assay development for in vitro in vivo correlations - Theory and case studies
    Rohrs, BR
    Skoug, JW
    Halstead, GW
    IN VITRO-IN VIVO CORRELATIONS, 1997, 423 : 17 - 30
  • [46] The Progress on the In Vivo-In Vitro Correlation (IVIVC) for Immediate Release Dosage Form as an Alternative to Bioavailability Studies
    Ostrowski, Michal
    Baczek, Tomasz
    CURRENT PHARMACEUTICAL ANALYSIS, 2010, 6 (04) : 289 - 298
  • [47] Formulation and In vitro Evaluation of Sustained Release Dosage Form with Taste Masking of Metformin Hydrochloride
    Bhoyar, P. K.
    Biyani, D. M.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 72 (02) : 184 - 190
  • [48] In Vitro-In Vivo Correlation of Tianeptine Sodium Sustained-Release Dual-Layer Tablets
    Lee, Ye-Ji
    Kim, Joo-Eun
    MOLECULES, 2022, 27 (09):
  • [49] Development and in vitro-in vivo evaluation of a novel sustained-release tablet based on constant-release surface
    Wang, Lele
    Duan, Tijie
    Gao, Yawen
    Liu, Heqing
    Sun, Rui
    Wu, Tong
    Tang, Jihui
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 105
  • [50] Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsules
    Kortejärvi, H
    Mikkola, J
    Bäckman, M
    Antila, S
    Marvola, M
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (01) : 87 - 95